Skip to content
Dose Brief
Menu
No. 65 here · Grade C

The Edit review

The Edit charges $259 a month for compounded semaglutide and $349 for tirzepatide, with first-month rates of $200 and $300 printed larger than the standing price.

Visit The Edit Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $259/mo (compounded)
Tirzepatide
From $349/mo (compounded)
Coverage
All 50 states claimed, no list published
Brand-name
Compounded only

Prices read from The Edit's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— New to the tracker on 1 September 2026, and read on the provider's own site rather than taken on trust: we checked https://theedithealth.com/ on 2026-09-01 and this row reflects what that page says. The line we publish is From $259/mo (compounded). There is no earlier reading of ours to compare it against yet.

The scorecard

The Edit scored on our six Brief Score factors. See the methodology.

Price Stability48/100
Supply Reliability87/100
Transparency94/100
Access Breadth90/100
Clinical Oversight80/100
Track Record79/100

The full report

We read The Edit’s own pages end to end and wrote up what the scorecard cannot hold — the price ladder, what the intake asks before it shows a number, and what the terms say that the marketing does not. The Edit review: $259 sema, $349 tirzepatide

What we like

  • The dispensing pharmacy is named with a street address and a phone number: The Pharmacy Hub in Miami.
  • The medical director is named with an NPI number, so the prescriber can be checked against the federal registry.
  • Standing prices for both molecules are on the product pages before any intake.
  • The three- and six-month plans state plainly that they are billed once at the start rather than monthly.

The caveats

  • The $200 and $300 first-order rates are printed larger than the standing $259 and $349, and the limited-time label carries no end date.
  • Those three- and six-month plans still print a per-month figure beside a charge taken in one payment.
  • All 50 states is claimed and hedged in the same paragraph, with no list published anywhere.
  • No 503A or 503B designation appears for the named pharmacy.
  • The terms describe a pharmacy network of which The Pharmacy Hub is only one named member, so who fills the prescription may vary.

The brief

Best for: Shoppers who want a named pharmacy and a named prescriber whose NPI number they can check. The Edit charges $259 a month for compounded semaglutide and $349 for tirzepatide, with first-month rates of $200 and $300 printed larger than the standing price.

Ranked #65 of 536 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Visit The Edit

Before you decide

The questions readers ask next after reading about The Edit.

Closest here

The providers scoring nearest The Edit — the realistic shortlist if you're weighing it.

Weighing The Edit against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs The Edit, and every provider that outranks it is listed on the The Edit alternatives ranking.

More providers we track (24)

505 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect The Edit's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on The Edit's site. Not medical advice; see our disclosure.

← Back to all rankings